Details of the Drug Combinations

General Information of This Drug (ID: DMUM7HZ)

Drug Name

Fluorouracil DMUM7HZ

Synonyms

5-Fluorouracil; 51-21-8; fluorouracil; 5-FU; Fluoroplex; Adrucil; Efudex; Carac; Fluracil; Fluoroblastin; 5-fluoropyrimidine-2,4(1H,3H)-dione; Kecimeton; Timazin; Carzonal; Efudix; Arumel; Fluril; Queroplex; Fluracilum; Ulup; 5-Fluoracil; Phthoruracil; Fluro Uracil; 5-Fluoro-2,4(1H,3H)-pyrimidinedione; Ftoruracil; Fluorouracilum; Efurix; Fluri; 5 Fluorouracil; Effluderm (free base); 5-fluoro-1H-pyrimidine-2,4-dione; Fluorouracilo; Fluroblastin; Phtoruracil; 2,4-Dihydroxy-5-fluoropyrimidine; 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-; Adrucil; Effluderm; Fluorouracile; Fluoruracil; Fluracedyl; Flurodex; Neofluor; Onkofluor; Ribofluor; Tetratogen; URF; Allergan Brand of Fluorouracil; Biosyn Brand of Fluorouracil; CSP Brand of Fluorouracil; Cinco FU; Dakota Brand of Fluorouracil; Dermatech Brand of Fluorouracil; Dermik Brandof Fluorouracil; Ferrer Brand of Fluorouracil; Fluoro Uracile ICN; Fluorouracil GRY; Fluorouracil Mononitrate; Fluorouracil Monopotassium Salt; Fluorouracil Monosodium Salt; Fluorouracil Potassium Salt; Fluorouracil Teva Brand; Fluorouracile Dakota; Fluorouracile [DCIT]; Fluorouracilo Ferrer Far; Gry Brand of Fluorouracil; Haemato Brand of Fluorouracil; Haemato fu; Hexal Brand of Fluorouracil; ICN Brand of Fluorouracil; Inhibits thymilidate synthetase; Medac Brand of Fluorouracil; Neocorp Brand of Fluorouracil; Onkoworks Brand of Fluorouracil; Ribosepharm Brand of Fluorouracil; Riemser Brand of Fluorouracil; Roche Brand of Fluorouracil; Teva Brand of Fluorouracil; F 6627; F0151; IN1335; U 8953; Adrucil (TN); Carac (TN); Dakota, Fluorouracile; Efudex (TN); Fluoro-Uracile ICN; Fluoro-uracile; Fluoro-uracilo; Fluoroplex (TN); Fluorouracil-GRY; Fluorouracilo [INN-Spanish]; Fluorouracilum [INN-Latin]; Haemato-fu; Ro 2-9757; U-8953; Ro-2-9757; Fluorouracil (JP15/USP/INN); Fluorouracil [USAN:INN:BAN:JAN]; 1-fluoro-1h-pyrimidine-2,4-dione; 2,4-Dioxo-5-fluoropryimidine; 2,4-Dioxo-5-fluoropyrimidine; 5 FU Lederle; 5 FU medac; 5 Fluorouracil biosyn; 5 HU Hexal; 5-FU (TN); 5-FU Lederle; 5-FU medac; 5-Faracil; 5-Fluor-2,4(1H,3H)-pyrimidindion; 5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]; 5-Fluor-2,4-dihydroxypyrimidin; 5-Fluor-2,4-dihydroxypyrimidin [Czech]; 5-Fluor-2,4-pyrimidindiol; 5-Fluor-2,4-pyrimidindiol [Czech]; 5-Fluoracil [German]; 5-Fluoracyl; 5-Fluoro-2,4-pyrimidinedione; 5-Fluoropyrimidin-2,4-diol; 5-Fluoropyrimidine-2,4-dione; 5-Fluorouracil-biosyn; 5-Fluoruracil; 5-Fluoruracil [German]; 5-Ftouracyl; 5-HU Hexal; 5-fluoro uracil; 5FU

Indication

Disease Entry	ICD 11	Status	REF
Adenocarcinoma	2D40	Approved	[1]
Biliary tract cancer	2C17	Approved	[1]
Colon adenocarcinoma	N.A.	Approved	[1]
Esophageal squamous cell carcinoma	2E60.1	Approved	[1]
Gastric intestinal type adenocarcinoma	N.A.	Approved	[1]
Gastroesophageal junction adenocarcinoma	2B71	Approved	[1]
Metastasis from malignant tumor of colon	N.A.	Approved	[1]
Pancreatic adenocarcinoma	N.A.	Approved	[1]
Rectal adenocarcinoma	2B92	Approved	[1]
Rectum mucinous adenocarcinoma	N.A.	Approved	[1]
Solid tumour/cancer	2A00-2F9Z	Approved	[2]
Colon cancer	2B90.Z	Investigative	[1]
Colon mucinous adenocarcinoma	N.A.	Investigative	[1]
Colorectal cancer	2B91.Z	Investigative	[3]
Gastric cancer	2B72	Investigative	[1]
Tumour	2A00-2F9Z	Investigative	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of Indication(s)

Therapeutic Class

Immunosuppressive Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

747 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Fluorouracil + PD-0325901	DC4XUHV	PD-0325901	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Lapatinib	DC042HW	Lapatinib	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Vinblastine	DCSYKKN	Vinblastine	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + RTB101	DCOPX9G	RTB101	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + SCH-900776	DC9MNFP	SCH-900776	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + 10-hydroxycamptothecin	DCJ1G8L	10-hydroxycamptothecin	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + SCH 727965	DCDBYUC	SCH 727965	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Erlotinib	DC0PXP4	Erlotinib	Adenocarcinoma (Cell Line: DLD1)	[5]
Fluorouracil + Erlotinib	DC6GJ5O	Erlotinib	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + MK-4827	DCH1B10	MK-4827	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Bortezomib	DC158YT	Bortezomib	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Topotecan	DCMTG98	Topotecan	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Sorafenib	DC1OA37	Sorafenib	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Taxol	DCI2O36	Taxol	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Vinorelbine	DCOTB31	Vinorelbine	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Vorinostat	DC2FVX8	Vorinostat	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Estramustine	DC6EJAY	Estramustine	Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2)	[5]
Fluorouracil + Dasatinib	DC3VSIP	Dasatinib	Adenocarcinoma (Cell Line: COLO320DM)	[5]
Fluorouracil + Dasatinib	DCADKI9	Dasatinib	Adenocarcinoma (Cell Line: DLD1)	[5]
Fluorouracil + Dasatinib	DC1PTVD	Dasatinib	Adenocarcinoma (Cell Line: HT29)	[5]
Fluorouracil + Dasatinib	DCMJ4QJ	Dasatinib	Adenocarcinoma (Cell Line: SW-620)	[5]
Fluorouracil + PD-0325901	DC7HONE	PD-0325901	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + PD-0325901	DC5X7DL	PD-0325901	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + PD-0325901	DCZBRAF	PD-0325901	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + PD-0325901	DCDZFYY	PD-0325901	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + PD-0325901	DCBAAWV	PD-0325901	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + PD-0325901	DCGQHNK	PD-0325901	Carcinoma (Cell Line: EFM192B)	[6]
Fluorouracil + PD-0325901	DC22TXQ	PD-0325901	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + PD-0325901	DCTG9JF	PD-0325901	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + PD-0325901	DC91D7D	PD-0325901	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + PD-0325901	DCK7CYM	PD-0325901	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Lapatinib	DC6MMP7	Lapatinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Lapatinib	DCN25FH	Lapatinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Lapatinib	DCDPWLJ	Lapatinib	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Lapatinib	DCYNRI3	Lapatinib	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Lapatinib	DCEPSYD	Lapatinib	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + Lapatinib	DC3FD7A	Lapatinib	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + Lapatinib	DCQHOGW	Lapatinib	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Lapatinib	DCQYT8T	Lapatinib	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Lapatinib	DC5P376	Lapatinib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Lapatinib	DCODSY6	Lapatinib	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + MK-1775	DC5NCO4	MK-1775	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + MK-1775	DC631VR	MK-1775	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + MK-1775	DCNHKBV	MK-1775	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + MK-1775	DCPJ54L	MK-1775	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + MK-1775	DCXXE5L	MK-1775	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + MK-1775	DC4JQTY	MK-1775	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + MK-1775	DC9P428	MK-1775	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + MK-1775	DCMW289	MK-1775	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Dexamethasone	DC6857R	Dexamethasone	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Dexamethasone	DC4A3FP	Dexamethasone	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + Dexamethasone	DCGJ44Y	Dexamethasone	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Dexamethasone	DCHTSSM	Dexamethasone	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + PMID28460551-Compound-2	DCNTWNJ	PMID28460551-Compound-2	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + PMID28460551-Compound-2	DCQ5WMI	PMID28460551-Compound-2	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + PMID28460551-Compound-2	DCHJLMV	PMID28460551-Compound-2	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + PMID28460551-Compound-2	DCSNU3J	PMID28460551-Compound-2	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + PMID28460551-Compound-2	DCDHCZI	PMID28460551-Compound-2	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + PMID28460551-Compound-2	DCKI9K3	PMID28460551-Compound-2	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + PMID28460551-Compound-2	DCZDAEL	PMID28460551-Compound-2	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + PMID28460551-Compound-2	DCLP3LF	PMID28460551-Compound-2	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + PMID28460551-Compound-2	DCDF0AX	PMID28460551-Compound-2	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Methotrexate	DCC3NNC	Methotrexate	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Methotrexate	DCA10WS	Methotrexate	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Methotrexate	DCYEO3D	Methotrexate	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Methotrexate	DCZXIUO	Methotrexate	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Vinblastine	DCIVGRH	Vinblastine	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Vinblastine	DC6NZAA	Vinblastine	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Vinblastine	DCKUELH	Vinblastine	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Vinblastine	DCRFSIY	Vinblastine	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Vinblastine	DCDW3EN	Vinblastine	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + Vinblastine	DCEQ7KQ	Vinblastine	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + Vinblastine	DCK0IM6	Vinblastine	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Vinblastine	DC3EIVI	Vinblastine	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Vinblastine	DC5FPC4	Vinblastine	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Vinblastine	DC66YRL	Vinblastine	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + RTB101	DCG6R2J	RTB101	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + RTB101	DCZ765I	RTB101	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + RTB101	DCLM10J	RTB101	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + RTB101	DCO29V1	RTB101	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + RTB101	DCU3Q8W	RTB101	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + RTB101	DCLWLID	RTB101	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + RTB101	DCQGEN5	RTB101	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + RTB101	DCEGTQB	RTB101	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + SCH-900776	DCUEXMJ	SCH-900776	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + SCH-900776	DCWJWRH	SCH-900776	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + SCH-900776	DCVG2RL	SCH-900776	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + SCH-900776	DCUP3WX	SCH-900776	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + SCH-900776	DCLL34N	SCH-900776	Carcinoma (Cell Line: EFM192B)	[6]
Fluorouracil + SCH-900776	DCOUDM4	SCH-900776	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + SCH-900776	DCBJGZ2	SCH-900776	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + SCH-900776	DCZ32VP	SCH-900776	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Gemcitabine	DCU1EKM	Gemcitabine	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Gemcitabine	DCM7JP9	Gemcitabine	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Gemcitabine	DCAHIF1	Gemcitabine	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + 10-hydroxycamptothecin	DC2YD4T	10-hydroxycamptothecin	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + 10-hydroxycamptothecin	DC8LLV4	10-hydroxycamptothecin	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + 10-hydroxycamptothecin	DCXKB9R	10-hydroxycamptothecin	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + 10-hydroxycamptothecin	DCI46IY	10-hydroxycamptothecin	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + 10-hydroxycamptothecin	DC9UZUW	10-hydroxycamptothecin	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + 10-hydroxycamptothecin	DCDYB8W	10-hydroxycamptothecin	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + SNX-2112	DCQVW73	SNX-2112	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + SNX-2112	DC7PUKI	SNX-2112	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + SNX-2112	DC30EOL	SNX-2112	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + SNX-2112	DC15OQS	SNX-2112	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + SNX-2112	DCLJ2EH	SNX-2112	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + SNX-2112	DCR9GPB	SNX-2112	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + SNX-2112	DCZ37GI	SNX-2112	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + SCH 727965	DCBU8L8	SCH 727965	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + SCH 727965	DC1S8V2	SCH 727965	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + SCH 727965	DCMXOVM	SCH 727965	Breast carcinoma (Cell Line: ZR751)	[6]
Fluorouracil + SCH 727965	DC09CDH	SCH 727965	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + SCH 727965	DC48PJC	SCH 727965	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + SCH 727965	DCH3H6P	SCH 727965	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + SCH 727965	DCL8X1Q	SCH 727965	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Erlotinib	DCW2L30	Erlotinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Erlotinib	DCMSHKT	Erlotinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Erlotinib	DCWW9WK	Erlotinib	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Erlotinib	DCISOID	Erlotinib	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Erlotinib	DCW622Q	Erlotinib	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Erlotinib	DCPS2ZQ	Erlotinib	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Erlotinib	DCTZ8JI	Erlotinib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Erlotinib	DCGU6MD	Erlotinib	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Metformin	DCOQHJN	Metformin	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Metformin	DCOUD0D	Metformin	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + Etoposide	DCQ8BUA	Etoposide	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Etoposide	DC0T007	Etoposide	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Etoposide	DCAYR7Q	Etoposide	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Etoposide	DC6S4TQ	Etoposide	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Etoposide	DC3MQS4	Etoposide	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Etoposide	DCU6D6H	Etoposide	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + MK-5108	DCO3423	MK-5108	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + MK-5108	DCYS5SM	MK-5108	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + MK-5108	DC37RHA	MK-5108	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + MK-5108	DC75LWR	MK-5108	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + MK-5108	DCCWWH1	MK-5108	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Mitomycin	DCEPLSW	Mitomycin	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Mitomycin	DCFECAP	Mitomycin	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Mitomycin	DCDVDSK	Mitomycin	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Mitomycin	DCN7R2N	Mitomycin	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Mitomycin	DCVOTYU	Mitomycin	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Mitomycin	DCWEHB8	Mitomycin	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Ridaforolimus	DCOW8Q8	Ridaforolimus	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Ridaforolimus	DCBAU8D	Ridaforolimus	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Ridaforolimus	DCINCZD	Ridaforolimus	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + Ridaforolimus	DCL2A35	Ridaforolimus	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + MK-4827	DCG10K0	MK-4827	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + MK-4827	DCOSN5K	MK-4827	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + MK-4827	DC05P9A	MK-4827	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + MK-4827	DCNWE86	MK-4827	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + MK-4827	DCZEIZS	MK-4827	Carcinoma (Cell Line: EFM192B)	[6]
Fluorouracil + MK-4827	DC07NMT	MK-4827	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + MK-4827	DCT785J	MK-4827	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + MK-4827	DC6DV7S	MK-4827	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + MK-4827	DC9OP8K	MK-4827	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + MK-4827	DCH4LI2	MK-4827	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Idarubicin	DC9QC0E	Idarubicin	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + Bortezomib	DCLI7MH	Bortezomib	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Bortezomib	DCD2GP2	Bortezomib	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Bortezomib	DC2HOI2	Bortezomib	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + Bortezomib	DC3V4UM	Bortezomib	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Bortezomib	DCVVB74	Bortezomib	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Bortezomib	DCJ0V7B	Bortezomib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Bortezomib	DCT8NSH	Bortezomib	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Topotecan	DCQFPBN	Topotecan	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Topotecan	DCVXN69	Topotecan	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Topotecan	DCSN8PB	Topotecan	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + GSK525762	DCZUO0V	GSK525762	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + GSK525762	DCM6Z4C	GSK525762	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + GSK525762	DCD36JN	GSK525762	Carcinoma (Cell Line: EFM192B)	[6]
Fluorouracil + GSK525762	DCGFOWN	GSK525762	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + GSK525762	DCP7MKO	GSK525762	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Sorafenib	DCFTSG6	Sorafenib	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Sorafenib	DCTQ3GZ	Sorafenib	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Sorafenib	DCIQXOM	Sorafenib	Breast carcinoma (Cell Line: ZR751)	[6]
Fluorouracil + Sorafenib	DC7WUBU	Sorafenib	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Sorafenib	DCDC8RI	Sorafenib	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Sorafenib	DCHI12T	Sorafenib	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + Sorafenib	DCNV46J	Sorafenib	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + Sorafenib	DC8LUK7	Sorafenib	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Sorafenib	DCOZXUJ	Sorafenib	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Sorafenib	DCLRWZY	Sorafenib	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + MK-2206	DC20KMI	MK-2206	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + MK-2206	DCBN8GW	MK-2206	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + MK-2206	DC5RLZZ	MK-2206	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + MK-2206	DCA5Y90	MK-2206	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + MK-2206	DCWXNMA	MK-2206	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + MK-2206	DCKYPZD	MK-2206	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + MK-2206	DC3G0Y5	MK-2206	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + MK-2206	DC13WV0	MK-2206	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + MK-2206	DCBPUXA	MK-2206	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Taxol	DCTE1J7	Taxol	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Taxol	DC67GFZ	Taxol	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Taxol	DC10K8O	Taxol	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + Taxol	DC3A7DU	Taxol	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Taxol	DC0JHJB	Taxol	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Taxol	DCC6H99	Taxol	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Taxol	DCKDNVO	Taxol	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Doxorubicin	DC58VZO	Doxorubicin	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Doxorubicin	DC6YBB6	Doxorubicin	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Vinorelbine	DCLIFSW	Vinorelbine	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Vinorelbine	DCRCLI4	Vinorelbine	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Vinorelbine	DCUD209	Vinorelbine	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Vinorelbine	DCK7RQX	Vinorelbine	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Vinorelbine	DCPTGX2	Vinorelbine	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Vinorelbine	DC3CU0I	Vinorelbine	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Vinorelbine	DCDCXNB	Vinorelbine	Invasive ductal carcinoma (Cell Line: T-47D)	[6]
Fluorouracil + Vinorelbine	DCA0WA1	Vinorelbine	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Vorinostat	DCF67C7	Vorinostat	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Vorinostat	DCKAO70	Vorinostat	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Vorinostat	DCRBV5T	Vorinostat	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Vorinostat	DC5BBUS	Vorinostat	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + Vorinostat	DCDPN2G	Vorinostat	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Vorinostat	DC0I5SA	Vorinostat	Colon carcinoma (Cell Line: RKO)	[6]
Fluorouracil + Vorinostat	DCEMXZ5	Vorinostat	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Estramustine	DC3391I	Estramustine	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Estramustine	DCQEYCI	Estramustine	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Estramustine	DC45OUK	Estramustine	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + Dasatinib	DCPGDU7	Dasatinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289)	[6]
Fluorouracil + Dasatinib	DCSRGQ8	Dasatinib	Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1)	[6]
Fluorouracil + Dasatinib	DCTGQMW	Dasatinib	Breast carcinoma (Cell Line: KPL1)	[6]
Fluorouracil + Dasatinib	DCFAKLL	Dasatinib	Breast carcinoma (Cell Line: OCUBM)	[6]
Fluorouracil + Dasatinib	DC73FQA	Dasatinib	Carcinoma (Cell Line: OV90)	[6]
Fluorouracil + Dasatinib	DCNJBAF	Dasatinib	Carcinoma (Cell Line: EFM192B)	[6]
Fluorouracil + Dasatinib	DCK2KXI	Dasatinib	Carcinoma (Cell Line: MDAMB436)	[6]
Fluorouracil + Dasatinib	DC74B5F	Dasatinib	Colon adenocarcinoma (Cell Line: LOVO)	[6]
Fluorouracil + Dasatinib	DCCF4DR	Dasatinib	Rectal adenocarcinoma (Cell Line: SW837)	[6]
Fluorouracil + PD-0325901	DCA2TH2	PD-0325901	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + PD-0325901	DCRMWFV	PD-0325901	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + PD-0325901	DCIO4WY	PD-0325901	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + PD-0325901	DC4TJW5	PD-0325901	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + PD-0325901	DCOJJMV	PD-0325901	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + PD-0325901	DCIII14	PD-0325901	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + PD-0325901	DC04YQK	PD-0325901	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + PD-0325901	DCTJ9L3	PD-0325901	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + PD-0325901	DCJYHPK	PD-0325901	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + PD-0325901	DC7RGZA	PD-0325901	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + PD-0325901	DCCPCYU	PD-0325901	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + PD-0325901	DCL1UMP	PD-0325901	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + PD-0325901	DCOM8WN	PD-0325901	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + PD-0325901	DCJVOG0	PD-0325901	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + PD-0325901	DCNEQ35	PD-0325901	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + PD-0325901	DCURTXP	PD-0325901	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + PD-0325901	DCVCSVJ	PD-0325901	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + PD-0325901	DC7T3FD	PD-0325901	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + PD-0325901	DCWCK5H	PD-0325901	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + PD-0325901	DCWJ31F	PD-0325901	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + PD-0325901	DCTKYQJ	PD-0325901	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + PD-0325901	DCEDZFB	PD-0325901	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + Lapatinib	DCE0NWM	Lapatinib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Lapatinib	DCPM3UR	Lapatinib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Lapatinib	DC344QR	Lapatinib	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Lapatinib	DC8IL4R	Lapatinib	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + Lapatinib	DCLOTM5	Lapatinib	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + Lapatinib	DCY3QKH	Lapatinib	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Lapatinib	DCDZIFI	Lapatinib	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Lapatinib	DCGF9B9	Lapatinib	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Lapatinib	DCYXUSM	Lapatinib	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Lapatinib	DCV5BD5	Lapatinib	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Lapatinib	DCDCQ05	Lapatinib	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Lapatinib	DCIP280	Lapatinib	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Lapatinib	DCBOX6B	Lapatinib	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Lapatinib	DC2IGMG	Lapatinib	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Lapatinib	DCKVIMN	Lapatinib	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Lapatinib	DCNRCUM	Lapatinib	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + Lapatinib	DCJG998	Lapatinib	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Lapatinib	DCAC28O	Lapatinib	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Lapatinib	DC1YNWU	Lapatinib	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Lapatinib	DCLEWTG	Lapatinib	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Lapatinib	DCO7O18	Lapatinib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + Lapatinib	DC3HPXN	Lapatinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Lapatinib	DC9CG9Q	Lapatinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Lapatinib	DCCVRAG	Lapatinib	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + MK-1775	DCWZYKI	MK-1775	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + MK-1775	DCWZTBH	MK-1775	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + MK-1775	DCQ4T8E	MK-1775	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + MK-1775	DCQ5MYW	MK-1775	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + MK-1775	DCTV9MU	MK-1775	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + MK-1775	DCE3BWE	MK-1775	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + MK-1775	DC353UD	MK-1775	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + MK-1775	DCLJJ4D	MK-1775	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + MK-1775	DCWAD6Y	MK-1775	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + MK-1775	DC5VH5L	MK-1775	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + MK-1775	DC00UCH	MK-1775	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + MK-1775	DCXGTM0	MK-1775	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + MK-1775	DCX73JT	MK-1775	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + MK-1775	DC4UY4A	MK-1775	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + MK-1775	DCAZQB6	MK-1775	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + MK-1775	DC3I9NU	MK-1775	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + MK-1775	DCUNP29	MK-1775	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + Dexamethasone	DCRSD1L	Dexamethasone	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Dexamethasone	DCJ2NML	Dexamethasone	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Dexamethasone	DCI6PEP	Dexamethasone	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + Dexamethasone	DCHTBPQ	Dexamethasone	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Dexamethasone	DCZ1L20	Dexamethasone	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Dexamethasone	DCHATNG	Dexamethasone	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Dexamethasone	DCHQETP	Dexamethasone	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Dexamethasone	DCFR4X8	Dexamethasone	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Dexamethasone	DCJUCI5	Dexamethasone	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + PMID28460551-Compound-2	DC1JE9J	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + PMID28460551-Compound-2	DCZRPB3	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + PMID28460551-Compound-2	DC5LD0Y	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + PMID28460551-Compound-2	DCPHJ1U	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + PMID28460551-Compound-2	DCVF79Y	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + PMID28460551-Compound-2	DCPDRF8	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + PMID28460551-Compound-2	DCYNZII	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + PMID28460551-Compound-2	DC31Q43	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + PMID28460551-Compound-2	DCJELQ3	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + PMID28460551-Compound-2	DCAKOF7	PMID28460551-Compound-2	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + PMID28460551-Compound-2	DCUORU1	PMID28460551-Compound-2	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + PMID28460551-Compound-2	DCEKOL5	PMID28460551-Compound-2	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + PMID28460551-Compound-2	DCU7U7Q	PMID28460551-Compound-2	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + PMID28460551-Compound-2	DCSI37N	PMID28460551-Compound-2	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + PMID28460551-Compound-2	DCVOHI1	PMID28460551-Compound-2	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + PMID28460551-Compound-2	DCFD7VJ	PMID28460551-Compound-2	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + PMID28460551-Compound-2	DCL8RC6	PMID28460551-Compound-2	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + PMID28460551-Compound-2	DCD7OX3	PMID28460551-Compound-2	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + PMID28460551-Compound-2	DCJ09HG	PMID28460551-Compound-2	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + PMID28460551-Compound-2	DCZ1J4V	PMID28460551-Compound-2	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + PMID28460551-Compound-2	DCWAWIT	PMID28460551-Compound-2	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + Cyclophosphamide	DCGX3V1	Cyclophosphamide	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Cyclophosphamide	DC0YQ4U	Cyclophosphamide	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Cyclophosphamide	DC7V6VG	Cyclophosphamide	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Cyclophosphamide	DCK7825	Cyclophosphamide	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Cyclophosphamide	DCF32CP	Cyclophosphamide	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Methotrexate	DCU11IM	Methotrexate	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Methotrexate	DC76WFZ	Methotrexate	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Methotrexate	DCXOF6Z	Methotrexate	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Methotrexate	DCKQR25	Methotrexate	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Methotrexate	DCWHU6J	Methotrexate	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Vinblastine	DC5AND3	Vinblastine	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Vinblastine	DCFE57P	Vinblastine	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Vinblastine	DC56B6L	Vinblastine	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Vinblastine	DCKN9F4	Vinblastine	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + Vinblastine	DCER0C9	Vinblastine	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + Vinblastine	DCAXXY6	Vinblastine	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Vinblastine	DCV12ZW	Vinblastine	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Vinblastine	DC09FAG	Vinblastine	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Vinblastine	DCAEZL0	Vinblastine	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Vinblastine	DC4Q2N9	Vinblastine	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Vinblastine	DCS9C87	Vinblastine	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Vinblastine	DCMAX6Z	Vinblastine	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Vinblastine	DCI8H2E	Vinblastine	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + Vinblastine	DC9PFU0	Vinblastine	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Vinblastine	DC9C0EB	Vinblastine	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + Vinblastine	DC77PEW	Vinblastine	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Vinblastine	DCJ4ACO	Vinblastine	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Vinblastine	DC5FPIE	Vinblastine	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Vinblastine	DC1ZX8G	Vinblastine	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Vinblastine	DCJ3MOT	Vinblastine	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + Vinblastine	DCC2I52	Vinblastine	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Vinblastine	DCLH3Q3	Vinblastine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Vinblastine	DCK9GF9	Vinblastine	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + Vinblastine	DCMC78C	Vinblastine	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + RTB101	DC17AQ8	RTB101	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + RTB101	DC7XW6B	RTB101	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + RTB101	DC6ACPP	RTB101	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + RTB101	DCM4AKW	RTB101	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + RTB101	DCCOZY4	RTB101	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + RTB101	DCY7J4Q	RTB101	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + RTB101	DCKQ07R	RTB101	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + RTB101	DCKU4TI	RTB101	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + RTB101	DCS4E7G	RTB101	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + RTB101	DCYGLLU	RTB101	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + RTB101	DCFE547	RTB101	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + RTB101	DCIOLQJ	RTB101	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + RTB101	DCC1IC6	RTB101	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + RTB101	DCNYI0V	RTB101	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + RTB101	DCBPVI0	RTB101	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + RTB101	DCZ1YYG	RTB101	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + RTB101	DCV659D	RTB101	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + RTB101	DCWW2DS	RTB101	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + RTB101	DCR1FWK	RTB101	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + RTB101	DCR8D0T	RTB101	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + RTB101	DCPV2CR	RTB101	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + SCH-900776	DCRMG4Y	SCH-900776	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + SCH-900776	DCS0473	SCH-900776	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + SCH-900776	DCYN63P	SCH-900776	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + SCH-900776	DC6MPZJ	SCH-900776	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + SCH-900776	DCL2671	SCH-900776	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + SCH-900776	DCS3HUI	SCH-900776	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + SCH-900776	DC2QNN5	SCH-900776	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + SCH-900776	DCV3SUT	SCH-900776	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + SCH-900776	DCSGNF4	SCH-900776	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + SCH-900776	DC767LN	SCH-900776	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + SCH-900776	DCP8QBU	SCH-900776	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + SCH-900776	DC4IO3Q	SCH-900776	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + SCH-900776	DCOFHPJ	SCH-900776	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + SCH-900776	DCKWYOV	SCH-900776	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + SCH-900776	DCNCE0A	SCH-900776	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + SCH-900776	DCVBV2H	SCH-900776	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + SCH-900776	DCLF6OC	SCH-900776	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + SCH-900776	DCUAKX2	SCH-900776	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + SCH-900776	DC566F3	SCH-900776	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + SCH-900776	DCDOPFF	SCH-900776	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + Gemcitabine	DCDI7RL	Gemcitabine	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Gemcitabine	DCZV1CV	Gemcitabine	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Gemcitabine	DC8XZDL	Gemcitabine	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Gemcitabine	DCI7OR3	Gemcitabine	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Gemcitabine	DC3DDW2	Gemcitabine	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Gemcitabine	DCA53PF	Gemcitabine	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Gemcitabine	DC942A5	Gemcitabine	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + Gemcitabine	DC34U36	Gemcitabine	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Gemcitabine	DCSVNOF	Gemcitabine	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Gemcitabine	DCENY78	Gemcitabine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCPD1NU	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + 10-hydroxycamptothecin	DC3CVP4	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCGO3UW	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + 10-hydroxycamptothecin	DC6CRUS	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCYRJ4S	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + 10-hydroxycamptothecin	DC956OX	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCBL645	10-hydroxycamptothecin	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCRGG7P	10-hydroxycamptothecin	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCWEM7J	10-hydroxycamptothecin	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCED75J	10-hydroxycamptothecin	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + 10-hydroxycamptothecin	DC06DKX	10-hydroxycamptothecin	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCC9M3U	10-hydroxycamptothecin	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCM5FI4	10-hydroxycamptothecin	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCY7K0S	10-hydroxycamptothecin	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + 10-hydroxycamptothecin	DC8WTOF	10-hydroxycamptothecin	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + 10-hydroxycamptothecin	DC83KN7	10-hydroxycamptothecin	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCHADAA	10-hydroxycamptothecin	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + 10-hydroxycamptothecin	DCABMER	10-hydroxycamptothecin	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + SNX-2112	DCB459C	SNX-2112	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + SNX-2112	DCUMV1B	SNX-2112	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + SNX-2112	DCPVN2O	SNX-2112	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + SNX-2112	DCS5VV4	SNX-2112	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + SNX-2112	DCFIFIE	SNX-2112	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + SNX-2112	DCQ2IKJ	SNX-2112	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + SNX-2112	DCORYRC	SNX-2112	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + SNX-2112	DC7G1VN	SNX-2112	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + SNX-2112	DCSE9TB	SNX-2112	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + SNX-2112	DCSSP2O	SNX-2112	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + SNX-2112	DCDXQFA	SNX-2112	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + SNX-2112	DC7Q5LA	SNX-2112	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + SNX-2112	DC5A7BY	SNX-2112	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + SCH 727965	DCYUJLJ	SCH 727965	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + SCH 727965	DCRNCMM	SCH 727965	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + SCH 727965	DC831GZ	SCH 727965	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + SCH 727965	DCI7RXL	SCH 727965	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + SCH 727965	DC0X9WM	SCH 727965	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + SCH 727965	DCG6BQX	SCH 727965	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + SCH 727965	DCK3AOJ	SCH 727965	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + SCH 727965	DCQK8AH	SCH 727965	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + SCH 727965	DCWQKGT	SCH 727965	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + SCH 727965	DCSMIZR	SCH 727965	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + SCH 727965	DC04700	SCH 727965	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + SCH 727965	DCPTEVM	SCH 727965	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + SCH 727965	DCIKPVF	SCH 727965	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + SCH 727965	DC569MT	SCH 727965	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + SCH 727965	DC9IR3D	SCH 727965	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + SCH 727965	DCUWABS	SCH 727965	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + SCH 727965	DC6YH9L	SCH 727965	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + SCH 727965	DC1L5UZ	SCH 727965	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + SCH 727965	DCRP1YB	SCH 727965	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + SCH 727965	DCBSK0K	SCH 727965	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + SCH 727965	DCTC3K1	SCH 727965	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + SCH 727965	DCZ3H5M	SCH 727965	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + Erlotinib	DCRDQ10	Erlotinib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Erlotinib	DCVWULN	Erlotinib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Erlotinib	DCYAQ85	Erlotinib	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Erlotinib	DC1FKDB	Erlotinib	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + Erlotinib	DCQLUV5	Erlotinib	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + Erlotinib	DC3DZHV	Erlotinib	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Erlotinib	DCGPT6R	Erlotinib	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Erlotinib	DCZZ5XF	Erlotinib	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Erlotinib	DCQVIX9	Erlotinib	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Erlotinib	DCECZA8	Erlotinib	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Erlotinib	DCA04XA	Erlotinib	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Erlotinib	DC48752	Erlotinib	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Erlotinib	DCJUCAV	Erlotinib	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Erlotinib	DC3I5GN	Erlotinib	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Erlotinib	DC3GSPS	Erlotinib	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Erlotinib	DCSUB9D	Erlotinib	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Erlotinib	DCEYIS9	Erlotinib	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Erlotinib	DCSC54Z	Erlotinib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + Erlotinib	DCFE5XZ	Erlotinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Erlotinib	DCDM2MA	Erlotinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Metformin	DCW8FFN	Metformin	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + Metformin	DC2VY7E	Metformin	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Metformin	DC0Y44F	Metformin	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Metformin	DCNODXQ	Metformin	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Metformin	DC5B4OB	Metformin	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Etoposide	DCZ8NYZ	Etoposide	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Etoposide	DCAF4PR	Etoposide	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Etoposide	DCA6FWF	Etoposide	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Etoposide	DCN3W7D	Etoposide	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Etoposide	DCPSPHV	Etoposide	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Etoposide	DCWJOGL	Etoposide	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Etoposide	DCZ2KI1	Etoposide	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Etoposide	DCB0IZO	Etoposide	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Etoposide	DCQ2ZZ3	Etoposide	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Etoposide	DCB3ZKZ	Etoposide	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Etoposide	DCA13HV	Etoposide	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Etoposide	DCA0TTX	Etoposide	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Etoposide	DC2EV2B	Etoposide	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Etoposide	DCZ4YOI	Etoposide	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + MK-5108	DCBAMAA	MK-5108	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + MK-5108	DCUJCNR	MK-5108	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + MK-5108	DC4U7JQ	MK-5108	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + MK-5108	DC41DNU	MK-5108	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + MK-5108	DCJDN30	MK-5108	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + MK-5108	DCSVXSP	MK-5108	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + MK-5108	DC8Q4TK	MK-5108	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + MK-5108	DC7B8OW	MK-5108	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + MK-5108	DCNZ1FN	MK-5108	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + MK-5108	DCL9MMF	MK-5108	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + MK-5108	DCJ0W1R	MK-5108	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + MK-5108	DC868I4	MK-5108	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + MK-5108	DCJL3S3	MK-5108	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Mitomycin	DC2LV6T	Mitomycin	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Mitomycin	DCX6QYU	Mitomycin	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Mitomycin	DCEJJ9K	Mitomycin	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Mitomycin	DCVIZPG	Mitomycin	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Mitomycin	DCKN7CW	Mitomycin	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Mitomycin	DCQEREL	Mitomycin	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Mitomycin	DCHY7NU	Mitomycin	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Mitomycin	DCKRLLF	Mitomycin	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Mitomycin	DC55XED	Mitomycin	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Ridaforolimus	DC5Z402	Ridaforolimus	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Ridaforolimus	DCBTUEN	Ridaforolimus	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Ridaforolimus	DC7P7DK	Ridaforolimus	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + Ridaforolimus	DCHKCZU	Ridaforolimus	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Ridaforolimus	DCMAB1Z	Ridaforolimus	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Ridaforolimus	DC9D2SW	Ridaforolimus	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Ridaforolimus	DCHY948	Ridaforolimus	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Ridaforolimus	DCMWW4Q	Ridaforolimus	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Ridaforolimus	DCGRAST	Ridaforolimus	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Ridaforolimus	DCP7FYQ	Ridaforolimus	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Ridaforolimus	DCS95YE	Ridaforolimus	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + Ridaforolimus	DCD7TJ8	Ridaforolimus	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Ridaforolimus	DCDAQ3J	Ridaforolimus	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + MK-4827	DCX6MDG	MK-4827	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + MK-4827	DCGDNQX	MK-4827	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + MK-4827	DCV8TUR	MK-4827	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + MK-4827	DCWJWNP	MK-4827	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + MK-4827	DC65EO8	MK-4827	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + MK-4827	DCMUOLT	MK-4827	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + MK-4827	DCW4TYL	MK-4827	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + MK-4827	DCBQXAQ	MK-4827	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + MK-4827	DCYZMU9	MK-4827	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + MK-4827	DCBJNI9	MK-4827	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + MK-4827	DCJKJF3	MK-4827	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + MK-4827	DCQ4ON8	MK-4827	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + MK-4827	DC8EEN4	MK-4827	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + MK-4827	DCVSPF4	MK-4827	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + MK-4827	DCLNK6P	MK-4827	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + MK-4827	DC1I1I5	MK-4827	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + MK-4827	DCS82RE	MK-4827	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + MK-4827	DC5MO8P	MK-4827	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + MK-4827	DCC1TVY	MK-4827	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + MK-4827	DCXM7SC	MK-4827	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + MK-4827	DCJMN6N	MK-4827	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + MK-4827	DCFMZ2J	MK-4827	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + Idarubicin	DCKS576	Idarubicin	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Idarubicin	DCOZD4A	Idarubicin	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + Idarubicin	DCYUGOD	Idarubicin	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Idarubicin	DCMJH9X	Idarubicin	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Idarubicin	DCJ0TFY	Idarubicin	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Idarubicin	DCWGBQB	Idarubicin	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Idarubicin	DCP73WX	Idarubicin	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + Idarubicin	DC0HO1F	Idarubicin	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Idarubicin	DC7N28I	Idarubicin	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Lomustine	DC758DG	Lomustine	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Lomustine	DCYE3G3	Lomustine	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Lomustine	DCPHRJD	Lomustine	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Lomustine	DCCQE92	Lomustine	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + Bortezomib	DCZ205Z	Bortezomib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Bortezomib	DC2TZE7	Bortezomib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Bortezomib	DC9BLAS	Bortezomib	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Bortezomib	DCLMC9Q	Bortezomib	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Bortezomib	DCNV7X6	Bortezomib	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Bortezomib	DC04RGO	Bortezomib	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Bortezomib	DCOCSVX	Bortezomib	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Bortezomib	DC62YJV	Bortezomib	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Bortezomib	DC1XZ4B	Bortezomib	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Bortezomib	DC6V07Q	Bortezomib	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + Bortezomib	DC4T49S	Bortezomib	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Bortezomib	DC4AQBY	Bortezomib	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Bortezomib	DC438XI	Bortezomib	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Bortezomib	DCR0HFH	Bortezomib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + Bortezomib	DCLNO8W	Bortezomib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Bortezomib	DCUR7DU	Bortezomib	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + Bortezomib	DCLXNJX	Bortezomib	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + Topotecan	DCZM2PH	Topotecan	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Topotecan	DC25NR0	Topotecan	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Topotecan	DC661LB	Topotecan	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Topotecan	DCUL2DD	Topotecan	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Topotecan	DC633RQ	Topotecan	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Topotecan	DCOS8R7	Topotecan	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Topotecan	DCN7AI7	Topotecan	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Topotecan	DCC80SK	Topotecan	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Topotecan	DCEVR8X	Topotecan	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Topotecan	DCUVC7L	Topotecan	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Topotecan	DCMZYDR	Topotecan	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Topotecan	DC9P84L	Topotecan	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Topotecan	DCUL5L3	Topotecan	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Topotecan	DCT0S2E	Topotecan	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + GSK525762	DC9J3N0	GSK525762	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + GSK525762	DCS7DXH	GSK525762	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + GSK525762	DC4SGAW	GSK525762	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + GSK525762	DCGFS5W	GSK525762	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + GSK525762	DC8CRK7	GSK525762	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + GSK525762	DC384GJ	GSK525762	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + GSK525762	DCZJ4Q3	GSK525762	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + GSK525762	DCHTGXY	GSK525762	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + GSK525762	DCRBQ6P	GSK525762	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + GSK525762	DC245NF	GSK525762	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + GSK525762	DCMWW3R	GSK525762	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + GSK525762	DC6G3CR	GSK525762	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + GSK525762	DCUB79E	GSK525762	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + GSK525762	DC6I9M1	GSK525762	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + Sorafenib	DCD61BM	Sorafenib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Sorafenib	DCJ9YIM	Sorafenib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Sorafenib	DC2A9B7	Sorafenib	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Sorafenib	DC0942V	Sorafenib	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + Sorafenib	DC0X6ZR	Sorafenib	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + Sorafenib	DCJXFRZ	Sorafenib	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Sorafenib	DCQNWMG	Sorafenib	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Sorafenib	DCKPDOA	Sorafenib	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Sorafenib	DC8L0XO	Sorafenib	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Sorafenib	DC37X0U	Sorafenib	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Sorafenib	DC23U0V	Sorafenib	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Sorafenib	DCUCN2J	Sorafenib	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + Sorafenib	DC3RDB7	Sorafenib	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Sorafenib	DCFIV0U	Sorafenib	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Sorafenib	DCMUSHW	Sorafenib	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + Sorafenib	DCV48SI	Sorafenib	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Sorafenib	DCRG3OY	Sorafenib	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + Sorafenib	DCX3HRI	Sorafenib	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Sorafenib	DC4R2WU	Sorafenib	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Sorafenib	DC4FGYG	Sorafenib	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Sorafenib	DCM7XB1	Sorafenib	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Sorafenib	DCGJ49J	Sorafenib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + Sorafenib	DC71C2M	Sorafenib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Sorafenib	DC08FW9	Sorafenib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Sorafenib	DCV07OB	Sorafenib	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + Sorafenib	DCEAFZX	Sorafenib	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + MK-2206	DC0I8DG	MK-2206	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + MK-2206	DC0KWKG	MK-2206	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + MK-2206	DCJCQM2	MK-2206	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + MK-2206	DCN9WRO	MK-2206	Adenocarcinoma (Cell Line: NCIH1650)	[7]
Fluorouracil + MK-2206	DCMXC3E	MK-2206	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + MK-2206	DC633P7	MK-2206	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + MK-2206	DCLJ2W7	MK-2206	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + MK-2206	DCXXULC	MK-2206	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + MK-2206	DCH3QKJ	MK-2206	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + MK-2206	DCMTF3U	MK-2206	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + MK-2206	DCR45E7	MK-2206	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + MK-2206	DCDFKU4	MK-2206	Adenocarcinoma (Cell Line: SW-620)	[7]
Fluorouracil + MK-2206	DC3MNK5	MK-2206	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + MK-2206	DCD0A69	MK-2206	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + MK-2206	DCRGFBL	MK-2206	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + MK-2206	DCO2LUU	MK-2206	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + MK-2206	DCYIN0N	MK-2206	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + MK-2206	DCCPCMI	MK-2206	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + MK-2206	DCQV0W9	MK-2206	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + MK-2206	DCYJSSX	MK-2206	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + MK-2206	DCTEETI	MK-2206	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + MK-2206	DCXXOGQ	MK-2206	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + MK-2206	DCYT3GM	MK-2206	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + MK-2206	DCKRQ3L	MK-2206	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + MK-2206	DCRT2ZU	MK-2206	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + Taxol	DCEC8CX	Taxol	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Taxol	DCIRXH1	Taxol	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Taxol	DC9W2G0	Taxol	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Taxol	DCB9UB3	Taxol	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Taxol	DCEZRBQ	Taxol	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Taxol	DC05QNU	Taxol	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Taxol	DCILUE1	Taxol	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Taxol	DCAP35Z	Taxol	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Taxol	DC4WJKZ	Taxol	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Taxol	DCNQGE1	Taxol	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Taxol	DCNZOVJ	Taxol	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + Taxol	DCEZPA1	Taxol	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Taxol	DC0INP8	Taxol	Malignant melanoma (Cell Line: HT144)	[7]
Fluorouracil + Taxol	DCDVT1R	Taxol	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Taxol	DCX4ZV9	Taxol	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Taxol	DC8JPSR	Taxol	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Taxol	DC334CL	Taxol	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Doxorubicin	DC061HP	Doxorubicin	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Doxorubicin	DCNNR32	Doxorubicin	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Doxorubicin	DCK13WM	Doxorubicin	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Doxorubicin	DC5XC55	Doxorubicin	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Doxorubicin	DC1UYX0	Doxorubicin	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Doxorubicin	DC0QZAW	Doxorubicin	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Doxorubicin	DCW8KS7	Doxorubicin	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Doxorubicin	DCLM2U9	Doxorubicin	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Doxorubicin	DCMR0KB	Doxorubicin	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Vinorelbine	DC2RLHK	Vinorelbine	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Vinorelbine	DC7UFC0	Vinorelbine	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Vinorelbine	DCFNYCJ	Vinorelbine	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Vinorelbine	DCPYQ2P	Vinorelbine	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Vinorelbine	DCQHWJZ	Vinorelbine	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Vinorelbine	DCJKC0A	Vinorelbine	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Vinorelbine	DCTWB80	Vinorelbine	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + Vinorelbine	DCEZWQI	Vinorelbine	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Vinorelbine	DCA2ANA	Vinorelbine	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Vinorelbine	DCDNTL5	Vinorelbine	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Vinorelbine	DCUZNZP	Vinorelbine	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Vinorelbine	DC9APMC	Vinorelbine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Vinorelbine	DC7PKTN	Vinorelbine	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + Vorinostat	DCW836T	Vorinostat	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Vorinostat	DC2FSRF	Vorinostat	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Vorinostat	DC5QHGP	Vorinostat	Adenocarcinoma (Cell Line: NCIH2122)	[7]
Fluorouracil + Vorinostat	DCV83WK	Vorinostat	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Vorinostat	DCILVFP	Vorinostat	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Vorinostat	DCEBINH	Vorinostat	Adenocarcinoma (Cell Line: DLD1)	[7]
Fluorouracil + Vorinostat	DCKOLOP	Vorinostat	Adenocarcinoma (Cell Line: HCT116)	[7]
Fluorouracil + Vorinostat	DCHJD2C	Vorinostat	Adenocarcinoma (Cell Line: HT29)	[7]
Fluorouracil + Vorinostat	DCK4R7R	Vorinostat	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Vorinostat	DC1N0E8	Vorinostat	Large cell lung carcinoma (Cell Line: NCI-H460)	[7]
Fluorouracil + Vorinostat	DC7KNJ5	Vorinostat	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Vorinostat	DCR7WDK	Vorinostat	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Vorinostat	DCAUUXL	Vorinostat	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Vorinostat	DCMZ78E	Vorinostat	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Vorinostat	DCG7SM4	Vorinostat	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Vorinostat	DCU7ZMB	Vorinostat	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + Vorinostat	DC52G1F	Vorinostat	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Vorinostat	DCGD4J5	Vorinostat	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Vorinostat	DC619NY	Vorinostat	Prostate carcinoma (Cell Line: VCAP)	[7]
Fluorouracil + Estramustine	DCNMZTZ	Estramustine	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Estramustine	DCQAC7B	Estramustine	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Estramustine	DC1HNM3	Estramustine	Adenocarcinoma (Cell Line: COLO320DM)	[7]
Fluorouracil + Estramustine	DCKS94D	Estramustine	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Estramustine	DCEXSZU	Estramustine	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Estramustine	DCDL0QH	Estramustine	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Estramustine	DCLG5ZV	Estramustine	Malignant melanoma (Cell Line: SKMEL30)	[7]
Fluorouracil + Estramustine	DCQ1IC9	Estramustine	Malignant melanoma (Cell Line: UACC62)	[7]
Fluorouracil + Estramustine	DCQOS6W	Estramustine	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Estramustine	DCHKTGK	Estramustine	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Estramustine	DCN500T	Estramustine	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Dasatinib	DCS1FGD	Dasatinib	Adenocarcinoma (Cell Line: CAOV3)	[7]
Fluorouracil + Dasatinib	DCR36T2	Dasatinib	Adenocarcinoma (Cell Line: OVCAR3)	[7]
Fluorouracil + Dasatinib	DCLZP7J	Dasatinib	Adenocarcinoma (Cell Line: A427)	[7]
Fluorouracil + Dasatinib	DC7PK1R	Dasatinib	Adenocarcinoma (Cell Line: NCIH23)	[7]
Fluorouracil + Dasatinib	DC3SSLW	Dasatinib	Adenocarcinoma (Cell Line: NCIH520)	[7]
Fluorouracil + Dasatinib	DCVPOSZ	Dasatinib	Amelanotic melanoma (Cell Line: A2058)	[7]
Fluorouracil + Dasatinib	DCBM1I7	Dasatinib	Germ cell tumour (Cell Line: PA1)	[7]
Fluorouracil + Dasatinib	DC4HPQT	Dasatinib	Malignant melanoma (Cell Line: A375)	[7]
Fluorouracil + Dasatinib	DCYM085	Dasatinib	Malignant melanoma (Cell Line: RPMI7951)	[7]
Fluorouracil + Dasatinib	DCJ4DG3	Dasatinib	Mesothelioma (Cell Line: MSTO)	[7]
Fluorouracil + Dasatinib	DC4CFT1	Dasatinib	Non small cell carcinoma (Cell Line: SKMES1)	[7]
Fluorouracil + Dasatinib	DCKEGOE	Dasatinib	Ovarian endometrioid adenocarcinoma (Cell Line: A2780)	[7]
Fluorouracil + Dasatinib	DC59XH6	Dasatinib	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[7]
Fluorouracil + Dasatinib	DCHOLHX	Dasatinib	Prostate carcinoma (Cell Line: LNCAP)	[7]
Fluorouracil + Dasatinib	DC36HKG	Dasatinib	Prostate carcinoma (Cell Line: VCAP)	[7]
------------------------------------------------------------------------------------


⏷ Show the Full List of 747 DrugCom(s)

1 Approved Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Leucovorin + Fluorouracil	DCZGWGK	Leucovorin	Colon cancer	[2]
------------------------------------------------------------------------------------

References

1	Fluorouracil FDA Label
2	Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
3	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
4	Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.
5	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
6	Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
7	Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.